News
2d
Zacks Investment Research on MSNTempus AI Boosts R&D Efforts Through Wide-Ranging Product LaunchesTempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...
Tempus AI continued to see dramatic revenue and gross profit growth in the first quarter, with year-over-year revenue up 75.4% and quarterly gross profit nearly doubling, the Chicago-based health ...
Tempus AI’s stock took a hit in trading May 28, falling 19% to $53.20 during the day following a short seller’s report that claimed the Chicago-based health tech company’s share price faces ...
Hosted on MSN6mon
Tempus AI Stock Surges 23% in 6 Months: Should You Snap It Up Now?Tempus continues to expect 2024 revenues of approximately $700 million, implying approximately 32% year-over-year growth, and -$105 million in adjusted EBITDA, an improvement of approximately $50 ...
Tempus AI TEM and Butterfly Network BFLY are two AI-driven healthcare infotech companies that have successfully reformed ... OSCR Oscar Health, Inc. 20.45-0.99 (-4.62%) GRYP Gryphon Digital ...
Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge and former House Speaker Nancy Pelosi revealed she's bet on the stock.
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025. Urmimala Biswas . Thu, Apr 10, 2025, 3:00 PM 4 min read. In This Article: BFLY-WS . HCAT . TEM .
Tempus AI, a company at the forefront of AI-driven precision medicine, reported a 33% year-over-year revenue increase to $180.9 million for Q3 2024 and announced its acquisition of Ambry Genetics ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the TD ...
Tempus AI, Inc. (NASDAQ: ... Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients. January 21, 2025 08:30 AM Eastern Standard Time.
Tempus AI is trading at a forward 12-month price-to-sales (P/S) ratio of 7.90, below its median of 8.14 over the last year. Butterfly Network’s forward sales multiple sits at 5.00, below its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results